Disease Attributes  >>  Cubicin (daptomycin)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cubicin (daptomycin) / Merck (MSD)
NCT00663403: Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)

Completed
4
8
US
Daptomycin, Cubicin
University of Michigan, Cubist Pharmaceuticals LLC
Critically Ill, Hemodialysis
04/09
04/09
NCT01549613: Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections

Completed
4
104
US
Daptomycin, Vancomycin
University of Cincinnati
Cellulitis, Skin Infections
07/13
07/13

Download Options